115 related articles for article (PubMed ID: 17313121)
1. [How I explore ... a patient with cutaneous melanoma: actualisation of an algorithm].
Pierard-Franchimont C; Piérard GE
Rev Med Liege; 2006 Dec; 61(12):837-43. PubMed ID: 17313121
[TBL] [Abstract][Full Text] [Related]
2. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
3. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
[TBL] [Abstract][Full Text] [Related]
4. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
5. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
Horn J; Lock-Andersen J; Sjøstrand H; Loft A
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):887-92. PubMed ID: 16586078
[TBL] [Abstract][Full Text] [Related]
6. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous melanoma: role of ultrasound in the assessment of locoregional spread.
Catalano O; Siani A
Curr Probl Diagn Radiol; 2010; 39(1):30-6. PubMed ID: 19931111
[TBL] [Abstract][Full Text] [Related]
8. Locoregional spread of cutaneous melanoma: sonography findings.
Catalano O; Caracò C; Mozzillo N; Siani A
AJR Am J Roentgenol; 2010 Mar; 194(3):735-45. PubMed ID: 20173153
[TBL] [Abstract][Full Text] [Related]
9. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum S-100B in melanoma patients before and after sentinel node biopsy.
Smit LH; Nieweg OE; Korse CM; Bonfrer JM; Kroon BB
J Surg Oncol; 2005 May; 90(2):66-9; discussion 69-70. PubMed ID: 15844182
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study.
Blum A; Schmid-Wendtner MH; Mauss-Kiefer V; Eberle JY; Kuchelmeister C; Dill-Müller D
Dermatology; 2006; 212(1):47-52. PubMed ID: 16319474
[TBL] [Abstract][Full Text] [Related]
13. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
[TBL] [Abstract][Full Text] [Related]
14. Role of ultrasound in the assessment of the sentinel node of melanoma patients.
Voit CA; van Akkooi AC; Eggermont AM
AJR Am J Roentgenol; 2010 Dec; 195(6):W474-5; author reply W476. PubMed ID: 21098184
[No Abstract] [Full Text] [Related]
15. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Hafner J
Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
[No Abstract] [Full Text] [Related]
17. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
[TBL] [Abstract][Full Text] [Related]
18. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
19. Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the ear.
Shpitzer T; Gutman H; Barnea Y; Steinmetz A; Guttman D; Ad-El D; Schneebaum S; Lerman H; Lievshitz G; Gur E
Melanoma Res; 2007 Dec; 17(6):365-9. PubMed ID: 17992119
[TBL] [Abstract][Full Text] [Related]
20. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.
Cochran AJ; Roberts A; Wen DR; Huang RR; Itakura E; Luo F; Binder SW
Pathology; 2004 Oct; 36(5):478-84. PubMed ID: 15370119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
